EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN OBESE NONVALVULAR ATRIAL FIBRILLATION PATIENTS: A POOLED CLAIMS DATABASE ANALYSIS

Authors :: Xiaoyan Li
Jack Mardekian
Steven Deitelzweig
Manuela Di Fusco
Huseyin Yuce
Amol D Dhamane
Xianying Pan
Allison Keshishian
Alessandra Bassalobre Garcia
Xuemei Luo
Amiee Kang
Lisa Rosenblatt
Gregory Y.H. Lip
Neeraja Balachander
Source :: Journal of the American College of Cardiology. 73:434
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.
Abstract: Obesity has an important impact on general health outcomes and is prevalent in nonvalvular atrial fibrillation (NVAF) patients. This study evaluated stroke/systemic embolism (SE) and major bleeding (MB) among obese NVAF patients using non-vitamin K antagonist oral anticoagulants (NOACs) in the

Subjects :: medicine.medical_specialty
medicine.drug_class
business.industry
Antagonist
Atrial fibrillation
Vitamin K antagonist
medicine.disease
Obesity
Internal medicine
medicine
Claims database
General health
Cardiology and Cardiovascular Medicine
business
Stroke
Major bleeding

Tools